fundvisualizer.com

Sarofim EquitySRFMX

Performance (before sales charge)

As of 03/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2023
Stock
85.09%
Non-U.S. Stock
14.80%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.11%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2023

Basic materials

2.58%

Consumer cyclical

12.50%

Financial services

16.01%

Real estate

0.00%

Consumer defensive

7.78%

Health care

13.86%

Utilities

0.00%

Communication services

5.05%

Energy

8.27%

Industrials

8.28%

Technology

25.56%

Top 10 holdings

As of 12/31/2023

Microsoft Corp
9.53%
Apple Inc
5.34%
Amazon.com Inc
5.05%
Novo Nordisk A/S ADR
4.89%
Visa Inc Class A
4.08%
Hess Corp
3.81%
UnitedHealth Group Inc
3.68%
Alphabet Inc Class C
3.47%
Texas Instruments Inc
3.42%
Lvmh Moet Hennessy Louis Vuitton SE ADR
3.05%
Fund assets

$110.21 Million

Share class

Other

Morningstar category

Large Blend

Expense ratio

0.70%

Investment objective

Growth and Income

Documents